title: [The treatment of lung cancer relapse after the lung resection].
abstract: The aim of the study was to analyze the patients with the relapse of tumors after lung resection.
  
  
  METHODS
  One hundred eight patients with lung cancer were operated at Lithuanian Institute of Oncology during period of 1992-2002. To 28 patients pneumonectomy was performed, 4 - bilobectomy, 51 - lobectomy, 23 - wedge resection, 2 - segmentectomy. According to the stage of tumor operations more often were performed in III stage of the disease - to 62 patients, in II - 20, in I - 12 and in the IV - 14. The most common histologic type of tumor was squamous cell carcinoma - 57 patients, adenocarcinoma - 29, small cell carcinoma - 12, anaplastic carcinoma - 4, other types of tumor were rare. The stage of disease had influence upon the time for the relapse of tumor. The dissemination of tumor was detected in 9 patients with II ir III stage of disease. The treatment of the relapse of lung tumor was the following was: 31 patients received radiotherapy, 4 - photodynamic therapy, 12 - radiotherapy with chemotherapy, 20 - chemotherapy.
  
  
  RESULTS
  According to the data of March 31, 2003, 98 patients died from carcinoma, 10 patients lived with the signs of disease. Median survival after relapse of tumor was better in patients with I stage of disease - 26.2 months, II - 20.7 months, III - 13.9 months, IV - 8.2 months.
  
  
  CONCLUSIONS
  In the case of locally extended tumor with metastases in regional lymph nodes after lung resection the relapse of tumor was most common. The treatment of the relapse of tumor in early stages of disease was most effective.
authors.affiliation: Institute of Oncology, Vilnius University, Santariskiu 1, 2021 Vilnius, Lithuania. algirdasj@is.lt
authors.forename: Algirdas
authors.initials: A
authors.lastname: Jackevicius
authors.forename: Saulius
authors.initials: S
authors.lastname: Cicenas
authors.forename: Dainius Amerigas
authors.initials: DA
authors.lastname: Piscikas
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000601:surgery*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000473:pathology / Q000601:surgery*; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000601:surgery*; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D009367:Neoplasm Staging; D010778:Photochemotherapy; D011013:Pneumonectomy; D011829:Radiation Dosage; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents; D002945:Cisplatin